12
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Juvenile-Onset Mixed Connective Tissue Disease: Clinical, Serological and Follow-up Data

, , &
Pages 157-160 | Received 05 Aug 1988, Published online: 12 Jul 2009

References

  • Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extract-able nuclear antigen (ENA). Am J Med 1972; 52: 148–59
  • Baldassare A., Weiss T., Auclair R., Zuckner J. Mixed connective tissue disease (MCTD) in children. Arthritis Rheum 1976; 19: 788
  • Singsen B. H., Bernstein B. H., Kornreich H. K., King K. K., Hansen V., Tan E. M. Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr 1977; 90: 893–900
  • Peskett S. A., Ansell B. M., Fizzman P., Howard A. Mixed connective tissue disease in children. Rheumatol Rehabil 1978; 17: 245–8
  • Rosenthal M. Sharp-Syndrom (mixed connective tissue disease) bei Kindern. Helv Paediat Acta 1978; 33: 251–8
  • Fraga A., Gudino J., Ramos-Niembro F., Alarcon-Segovia D. Mixed connective tissue disease in childhood. Relationship with Sjögren's syndrome. Am J Dis Child 1978; 132: 263–5
  • Oetgen W. J., Boice J. A., Lawless O. J. Mixed connective tissue disease in children and adolescents. Pediatrics 1981; 67: 333–7
  • Eberhardt K., Svantesson H., Svensson B. Follow-up study of 6 children presenting with a MCTD-like syndrome. Scand J Rheumatol 1981; 10: 62–4
  • Savouret J. F., Chudwin D. S., Wara D. W., Ammann A. J., Cowan M. J., Miller W. L. Clinical and laboratory findings in childhood mixed connective disease: Presence of antibody to ribonucleo-protein containing the small nuclear ribonucleic acid U1. J Pediatr 1983; 102: 841–6
  • Itzkowitch D., Alexander M., Famaey J. P., Appelboom T. Overlapping connective tissue diseases in children. Clin Rheumatol 1983; 2: 375–80
  • Allen R. C., St-Cyr C., Maddison P. J., Ansell B. M. Overlap connective tissue syndromes. Arch Dis Childh 1986; 61: 284–8
  • Habets W. J., de Rooij D. J., Salden M. H., Verhagen A. P., van Eekelen C. A., van de Putte L. B., van Venrooij W. J. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 1983; 54: 265–76
  • Pettersson I., Wang G., Smith E. I., Wigzell H., Hedfors E., Hom J., Sharp G. C. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum 1986; 29: 986–96
  • Habets W. J., de Rooij D. J., Hoet M. H., van de Putte L. B., van Venrooij W. J. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol 1985; 59: 457–66
  • Habets W. J., Hoet M. H., Sillekens P. T. G., de Rooij D. J., van de Putte L. B., van Venrooij W. J. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens. Clin Exp Immunol 1989, (in press).
  • Habets W. J., Berden J. H. M., Hoch S. O., van Venrooij W. J. Further characterization and subcellular localization of Sm and Ul ribonucleoprotein antigens. Eur J Immunol 1985; 15: 992–7
  • de Rooij D. J., van de Putte L. B., Habets W. J., Verbeek A. L., van Venrooij W. J. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Scand J Rheumatol 1988; 17: 353–64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.